Pure Communications, Inc.

Pure Communications, Inc. http://purecommunicationsinc.com http://purecommunicationsinc.com Pure Communications Inc. is an integrated communications agency specializing in public relations, investor relations and marketing communications for the life sciences industry. http://purecommunicationsinc.comadmin/images/logo.gif Pure Communications, Inc. http://purecommunicationsinc.com en-us New Clinical Data Highlighting Foundation Medicine's Comprehensive Cancer Genomic Profile to be Presented at 2012 ASCO Annual Meeting Thu, 17 May 2012 06:10:54 EST Pure Communications, Inc. AVEO and Astellas Announce Positive Findings from TIVO-1 Superiority Study of Tivozanib in First-Line Advanced RCC Thu, 17 May 2012 06:04:26 EST Pure Communications, Inc. EndoBarrier Therapy to be Featured at Digestive Disease Week 2012 Mon, 14 May 2012 06:36:45 EST Pure Communications, Inc. NinePoint Medical to Unveil NvisionVLE Imaging System at Digestive Diseases Week 2012 Fri, 11 May 2012 06:04:45 EST Pure Communications, Inc. Alcresta Launches Innovative Enzyme-Based Nutritional Company; Secures $10 Million Series A Round Tue, 17 Apr 2012 06:01:00 EST Pure Communications, Inc. OvaScience Secures $37 Million in Series B Financing Wed, 04 Apr 2012 05:30:02 EST Pure Communications, Inc. Tokai Pharmaceuticals' Galeterone Well-Tolerated in Patients with Advanced Prostate Cancer; Phase 1 Data Presented at AACR Annual Meeting 2012 Mon, 02 Apr 2012 06:00:38 EST Pure Communications, Inc. Allena Pharmaceuticals Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies Wed, 28 Mar 2012 05:37:07 EST Pure Communications, Inc. NinePoint Medical Initiates Clinical Trial Of Nvision VLE Imaging System; Program On Track For Commercial Launch In 2013 Wed, 22 Feb 2012 14:33:55 EST Pure Communications, Inc. Foundation Medicine and Dana Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer Mon, 13 Feb 2012 08:47:06 EST Pure Communications, Inc. Ember Announces Nature Publication of Brown Fat Biology Data; Program Exclusively Licensed from the Dana-Farber Cancer Institute Wed, 11 Jan 2012 08:59:46 EST Pure Communications, Inc. Foundation Medicine Announces Collaboration with Sanofi Tue, 10 Jan 2012 08:59:06 EST Pure Communications, Inc. Third Rock Ventures and Sanofi Announce Launch of Warp Drive Bio; Broad Strategic Partnership Builds Innovative Genomics Search Engine to Reveal Nature's Drugs Tue, 10 Jan 2012 08:57:58 EST Pure Communications, Inc. NinePoint Medical Receives FDA 510(k) Clearance for Nvision VLE Imaging System Thu, 05 Jan 2012 11:31:33 EST Pure Communications, Inc. Third Rock Ventures Launches Ember Therapeutics to Address Critical Need for Novel Treatments for Metabolic Disease Thu, 15 Dec 2011 07:03:02 EST Pure Communications, Inc. Dicerna Pharmaceuticals Announces First DsiRNA Therapeutic Candidate Selected for Development, Triggering $5 Million Milestone Payment Thu, 15 Dec 2011 07:02:40 EST Pure Communications, Inc. GI Dynamics, Inc. Expands Availability of the EndoBarrier Through Two New Centers of Excellence in Germany Wed, 14 Dec 2011 06:55:01 EST Pure Communications, Inc. Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing Tue, 13 Dec 2011 06:56:14 EST Pure Communications, Inc. EnVivo Pharmaceuticals Presents Positive Comprehensive Phase 2b Study Results in Schizophrenia at American College of Neuropsychopharmacology Annual Meeting Mon, 05 Dec 2011 06:56:18 EST Pure Communications, Inc. Agios Secures $78 Million in Oversubscribed Series C Financing Thu, 17 Nov 2011 06:51:59 EST Pure Communications, Inc. Allena Pharmaceuticals Launches with $15 Million Series A Round Wed, 16 Nov 2011 07:20:49 EST Pure Communications, Inc. Roche and Aileron Therapeutics Expand Collaboration for Stapled Peptide Drugs Wed, 16 Nov 2011 07:19:30 EST Pure Communications, Inc. InfraReDx Announces the Launch of the TVC Imaging System for True Vessel Characterization of Coronary Artery Disease Mon, 07 Nov 2011 06:12:03 EST Pure Communications, Inc. Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of EXPAREL For Postsurgical Pain Management Mon, 31 Oct 2011 06:21:06 EST Pure Communications, Inc. Third Rock Ventures Launches SAGE Therapeutics to Address CNS Disorders with Critical Unmet Needs Tue, 18 Oct 2011 07:32:25 EST Pure Communications, Inc.